Gene Page: CXCL8
Summary ?
GeneID | 3576 |
Symbol | CXCL8 |
Synonyms | GCP-1|GCP1|IL8|LECT|LUCT|LYNAP|MDNCF|MONAP|NAF|NAP-1|NAP1 |
Description | C-X-C motif chemokine ligand 8 |
Reference | MIM:146930|HGNC:HGNC:6025|Ensembl:ENSG00000169429|HPRD:00909|Vega:OTTHUMG00000151316 |
Gene type | protein-coding |
Map location | 4q13-q21 |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenic,schizophrenias | Click to show details |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs10915489 | chr1 | 4321466 | IL8 | 3576 | 0.01 | trans | ||
rs1342707 | chr1 | 147264296 | IL8 | 3576 | 0.02 | trans | ||
rs10494951 | chr1 | 212429258 | IL8 | 3576 | 0.1 | trans | ||
rs2907143 | chr1 | 243147434 | IL8 | 3576 | 0 | trans | ||
rs1437972 | chr2 | 100987386 | IL8 | 3576 | 0.08 | trans | ||
rs1597005 | chr2 | 116736707 | IL8 | 3576 | 0.01 | trans | ||
rs2218030 | chr2 | 184261431 | IL8 | 3576 | 0.08 | trans | ||
snp_a-1974890 | 0 | IL8 | 3576 | 0.02 | trans | |||
rs16846456 | chr3 | 172757337 | IL8 | 3576 | 0.01 | trans | ||
rs17052594 | chr4 | 167698562 | IL8 | 3576 | 0.03 | trans | ||
rs1678893 | chr5 | 31763244 | IL8 | 3576 | 0.08 | trans | ||
rs31304 | chr5 | 52942082 | IL8 | 3576 | 5.276E-5 | trans | ||
rs888819 | chr5 | 80257108 | IL8 | 3576 | 0.01 | trans | ||
rs10515260 | chr5 | 97076547 | IL8 | 3576 | 0.01 | trans | ||
rs9313842 | chr5 | 159690030 | IL8 | 3576 | 0 | trans | ||
rs7716085 | chr5 | 172099132 | IL8 | 3576 | 0.12 | trans | ||
rs11749499 | chr5 | 172288696 | IL8 | 3576 | 0.07 | trans | ||
rs11743007 | chr5 | 172288906 | IL8 | 3576 | 0.07 | trans | ||
rs7822021 | chr8 | 8145522 | IL8 | 3576 | 0.01 | trans | ||
rs9325708 | chr8 | 12402940 | IL8 | 3576 | 0.09 | trans | ||
rs1355060 | chr8 | 118717710 | IL8 | 3576 | 0.18 | trans | ||
rs2280828 | chr8 | 118762435 | IL8 | 3576 | 0.17 | trans | ||
rs2082711 | chr9 | 83109430 | IL8 | 3576 | 0.08 | trans | ||
rs11029936 | chr11 | 27338854 | IL8 | 3576 | 0.1 | trans | ||
rs2512874 | chr11 | 131461291 | IL8 | 3576 | 1.959E-5 | trans | ||
rs7329574 | chr13 | 92663432 | IL8 | 3576 | 0.05 | trans | ||
rs6491786 | chr13 | 104328014 | IL8 | 3576 | 0.09 | trans | ||
rs9519136 | chr13 | 104332406 | IL8 | 3576 | 0.09 | trans | ||
rs9324006 | chr14 | 99505533 | IL8 | 3576 | 0.07 | trans | ||
rs6575709 | chr14 | 99506341 | IL8 | 3576 | 0.01 | trans | ||
rs8028951 | chr15 | 27187231 | IL8 | 3576 | 0.04 | trans | ||
rs2711647 | chr15 | 54235527 | IL8 | 3576 | 0.12 | trans | ||
rs6497089 | chr15 | 94163348 | IL8 | 3576 | 0.09 | trans | ||
rs16955255 | chr16 | 81420130 | IL8 | 3576 | 0.17 | trans | ||
rs4303487 | chr16 | 90033254 | IL8 | 3576 | 0 | trans | ||
rs16976379 | chr18 | 40198836 | IL8 | 3576 | 0 | trans | ||
rs10425739 | chr19 | 29582202 | IL8 | 3576 | 0.04 | trans | ||
rs11882031 | chr19 | 56193661 | IL8 | 3576 | 0.03 | trans | ||
rs6076060 | chr20 | 23345068 | IL8 | 3576 | 0.01 | trans | ||
rs805944 | chr20 | 38261717 | IL8 | 3576 | 0.07 | trans | ||
rs1701853 | chr20 | 38266160 | IL8 | 3576 | 0.07 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
HLA-F | 0.67 | 0.70 |
TINAGL1 | 0.65 | 0.73 |
HLA-E | 0.64 | 0.69 |
FGR | 0.64 | 0.69 |
HLA-B | 0.63 | 0.70 |
C1QTNF1 | 0.63 | 0.73 |
APOL3 | 0.63 | 0.68 |
HLA-C | 0.61 | 0.66 |
ST6GALNAC1 | 0.61 | 0.67 |
GBP2 | 0.61 | 0.68 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
ZNF821 | -0.57 | -0.60 |
ZNF671 | -0.57 | -0.61 |
NT5C3 | -0.56 | -0.62 |
MPP3 | -0.56 | -0.61 |
STMN1 | -0.56 | -0.63 |
ZNF354A | -0.56 | -0.61 |
ZBED5 | -0.56 | -0.63 |
DUSP12 | -0.56 | -0.61 |
GSTA4 | -0.56 | -0.60 |
DEM1 | -0.56 | -0.58 |
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
CCL4 | ACT2 | AT744.1 | G-26 | LAG1 | MGC104418 | MGC126025 | MGC126026 | MIP-1-beta | MIP1B | MIP1B1 | SCYA2 | SCYA4 | chemokine (C-C motif) ligand 4 | - | HPRD | 8077676 |
CCL5 | D17S136E | MGC17164 | RANTES | SCYA5 | SISd | TCP228 | chemokine (C-C motif) ligand 5 | Reconstituted Complex | BioGRID | 11509627 |
CHUK | IKBKA | IKK-alpha | IKK1 | IKKA | NFKBIKA | TCF16 | conserved helix-loop-helix ubiquitous kinase | The IL-8 promoter interacts with IKK-alpha. | BIND | 15494311 |
DARC | CCBP1 | CD234 | Dfy | FY | GPD | GpFy | WBCQ1 | Duffy blood group, chemokine receptor | - | HPRD | 9921412 |
EP300 | KAT3B | p300 | E1A binding protein p300 | The IL-8 promoter interacts with p300. | BIND | 15494311 |
GNAI2 | GIP | GNAI2B | H_LUCA15.1 | H_LUCA16.1 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | - | HPRD,BioGRID | 8662698 |
HDAC3 | HD3 | RPD3 | RPD3-2 | histone deacetylase 3 | The IL-8 promoter interacts with HDAC3. | BIND | 15494311 |
HIST3H3 | H3.4 | H3/g | H3FT | H3t | MGC126886 | MGC126888 | histone cluster 3, H3 | The IL-8 promoter interacts with phosphorylated and/or acetylated H3. | BIND | 15494311 |
IKBKB | FLJ40509 | IKK-beta | IKK2 | IKKB | MGC131801 | NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | The IL-8 promoter interacts with IKK-beta. | BIND | 15494311 |
IL8 | CXCL8 | GCP-1 | GCP1 | LECT | LUCT | LYNAP | MDNCF | MONAP | NAF | NAP-1 | NAP1 | interleukin 8 | - | HPRD,BioGRID | 2184886 |
IL8RA | C-C | C-C-CKR-1 | CD128 | CD181 | CDw128a | CKR-1 | CMKAR1 | CXCR1 | IL8R1 | IL8RBA | interleukin 8 receptor, alpha | - | HPRD | 1840701 |
IL8RA | C-C | C-C-CKR-1 | CD128 | CD181 | CDw128a | CKR-1 | CMKAR1 | CXCR1 | IL8R1 | IL8RBA | interleukin 8 receptor, alpha | The amino terminus of CXCR1 interacts with IL-8. This interaction was modeled on a demonstrated interaction between rabbit CXCR1 and human IL-8. | BIND | 15133028 |
IL8RB | CD182 | CDw128b | CMKAR2 | CXCR2 | IL8R2 | IL8RA | interleukin 8 receptor, beta | - | HPRD,BioGRID | 8702798 |9464567 |
NCOR2 | CTG26 | SMRT | SMRTE | SMRTE-tau | TNRC14 | TRAC-1 | TRAC1 | nuclear receptor co-repressor 2 | The IL-8 promoter interacts with SMRT. | BIND | 15494311 |
NFKB1 | DKFZp686C01211 | EBP-1 | KBF1 | MGC54151 | NF-kappa-B | NFKB-p105 | NFKB-p50 | p105 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | The IL-8 promoter interacts with p50. | BIND | 15494311 |
POLR2A | MGC75453 | POLR2 | POLRA | RPB1 | RPBh1 | RPO2 | RPOL2 | RpIILS | hRPB220 | hsRPB1 | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | The IL-8 promoter interacts with Pol II. | BIND | 15494311 |
RELA | MGC131774 | NFKB3 | p65 | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | The IL-8 promoter interacts with p65. | BIND | 15494311 |
SDC1 | CD138 | SDC | SYND1 | syndecan | syndecan 1 | - | HPRD,BioGRID | 12902511 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
NABA SECRETED FACTORS | 344 | 197 | All SZGR 2.0 genes in this pathway |
NABA MATRISOME ASSOCIATED | 753 | 411 | All SZGR 2.0 genes in this pathway |
NABA MATRISOME | 1028 | 559 | All SZGR 2.0 genes in this pathway |